Healthcare News: Vietnam – US Collaboration on Anti-Infection Technology
Vietnamese Ministry of Health Discusses Clinical Trials for Antimicrobial Endotracheal Tubes
On the afternoon of December 8 in Hanoi, Deputy Minister of Health Đỗ Xuân Tuyên hosted a working session with a delegation from the Golding Brothers Partners Group and H. William, Inc (USA), led by Mr. Jay Golding, Chairman of Health Board No. 8 and Chairman of Golding Brothers Partners.
The Golding Brothers Partners Group, which is actively engaged in the medical device and Biotechnology (Biotech) sectors, focuses on addressing global healthcare challenges, particularly hospital-acquired infections (HAIs) and antimicrobial resistance (AR) or “superbugs.”
Mr. Jay Golding expressed satisfaction with the positive development of the Vietnam – US comprehensive partnership, especially in the health sector. He introduced the Group’s operational model and voiced a desire to undertake significant collaborative projects in Vietnamese healthcare.
The Group proposed conducting clinical trials for a technology that involves coating endotracheal tubes with the active substance Ceragenins. Specifically, the CeraShield™ endotracheal tube with this coating is designed to prevent the adherence and growth of harmful bacteria and fungi post-surgery.
The meeting included a presentation on the features, utility, patient value, and current clinical research effectiveness of the CeraShield™ tube. Trials at hospitals in Canada have indicated that the product helps reduce the risk of lung infections, particularly in patients on mechanical ventilation in the ICU—a leading cause of in-hospital mortality.
Deputy Minister Đỗ Xuân Tuyên affirmed that preventing post-operative infections is a crucial and complex task for the health sector, requiring close cooperation among all stakeholders. He noted that the Ministry of Health prioritizes measures like raising awareness, improving infrastructure, and effectively applying prevention methods.
The Deputy Minister assigned Bạch Mai Hospital to coordinate research efforts with the Golding Brothers Partners Group and H. William, Inc. to finalize the legal documentation for the Ministry’s review and approval of the clinical trial cooperation program.
The Ministry of Health welcomed the initiative, committing to provide all favorable conditions and the necessary legal framework for the company to collaborate on trials aimed at reducing/eliminating post-operative bacteria. The goal is to enhance treatment efficacy at Bạch Mai Hospital, with the potential for nationwide expansion following successful and effective results, ultimately reducing patient costs and recovery time.
